logo

Cell Proliferation Kit Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Method (Colorimetry, Fluorescence, and Others), Assay Type, End-user and Geography.

Home Industry Reports Healthcare Cell Proliferation Kit Market - Growth, Trends, COVID-19 Impact, and Forecasts ( ...

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Cell Proliferation Kit (CPK) Market is expected to register a CAGR of 7.5% during the forecast period. The major factors attributing to the growth of the market are rising volume of patients diagnosed with cancer, tumors and ongoing R&D activities across the globe. As per World health Organization report, cancer is a leading cause of death worldwide and estimated that nearly 9.6 million deaths in 2018. Also, lung cancer was identified as the most common cancer leading to death with 1.76 million deaths in 2018. Thus, growing prevalence of these diseases resulted in earlier assessment of viable cell-count, metabolic activity for effective treatment fuels the market growth. Furthermore, rise in government initiatives to control the healthcare burden, and growing healthcare awareness among are likely boost the Cell Proliferation Kit market.

Scope of the Report

Cell proliferation is a process of cell replication, which plays a key role from the time of embryogenesis to maintenance of adult tissue homoeostasis by recycling the old cells with new cells. In a few disease conditions like cancer, abnormal cell proliferation is observed. Thus, cell proliferation assay kits gained traction in clinical diagnosis of various disease indications in both in vitro and in vivo conditions. These are used for investigational studies of cell activation, assessing cytotoxicity & clinically, in order to determine the therapeutic efficacy. As per the scope of the report, various types of cell proliferation kits were discussed in detail.

Assay Type
DNA Synthesis Cell Proliferation Assay
Metabolic Activity Cell Proliferation Assay
Antigen Associated Cell Proliferation Assay
Method
Colorimetry
Fluorescence
Others
End-user
Pharma & Biotech Companies
Academic & Research Institutes
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Colorimetry Sub-segment is Expected to Hold a Major Market Share in the Cell Proliferation Kit Market

Colorimetry holds a significant market share in Cell Proliferation Kit market over the forecast period. The dominance is owing to increased adoption as measuring markers of cell activity. Huge demand for the method is due to their cost effectiveness, easier retrieval of high-throughput data, and key role in assessment of therapeutic efficacy. This method is widely employed determining various cellular activity such as DNA synthesis, metabolic activity, ATP production, the number of cells present etc., Various types of colorimetric assays like WST-1, WST-8, XTT, MTT, and others are available specific to tests. Thus, above mentioned factors are expected to fuel the growth of the segment.

Number_of_New_Cancer_Cases 2020 in US.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the cell proliferation kit market. The dominance is due to growing number of new cancer cases like melanoma, urothelial carcinoma, lung cancer, and others each year in the region. Also, the presence of huge population of baby boomers leads to huge volume of elderly people who are at the risk of cancers. According to the estimates published by the American Cancer Society for the year 2020, lung cancer is the second most common cancer leading to 135,720 deaths in both men and women. Also, as per Thyroid Cancer Survivors Association, thyroid cancer affects nearly 52,890 new cases in the United States in 2020, which increased from 52,070 cases in the year 2019. Thus, growing cancer cases leads to increased demand for determining the growth rate of cellular population driving the growth of the market. Furthermore, ongoing research activities in oncology by key pharma and biotech companies necessitates the use of these kits to determine the therapeutic efficiency of drugs. Therefore, due to above mentioned factors expected to boost the cell proliferation kit market in the region to a large extent during the forecast period.

Mordor Intelligence

Competitive Landscape

The cell proliferation kit market is moderately competitive and consists of a several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Merck KGaA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Becton, Dickinson and Company, and Agilent Technologies Inc (BioTek Instruments Inc).

Cell Proliferation Kit - CL.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Technological Advancements in Cell-based Methodologies

      2. 4.2.2 Rising Prevalence of Chronic Diseases and Lifestyle Disorders

      3. 4.2.3 Increasing Application in Drug Screening

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Skilled Personnel to Operate these Technologies

      2. 4.3.2 High Maintenance and Operational Costs

      3. 4.3.3 Lesser Sensitive Results with Smaller Samples of Cells

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Assay Type

      1. 5.1.1 DNA Synthesis Cell Proliferation Assay

      2. 5.1.2 Metabolic Activity Cell Proliferation Assay

      3. 5.1.3 Antigen Associated Cell Proliferation Assay

    2. 5.2 Method

      1. 5.2.1 Colorimetry

      2. 5.2.2 Fluorescence

      3. 5.2.3 Others

    3. 5.3 End-user

      1. 5.3.1 Pharma & Biotech Companies

      2. 5.3.2 Academic & Research Institutes

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific Inc

      2. 6.1.2 Merck KGaA

      3. 6.1.3 Bio-Rad Laboratories Inc

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Agilent Technologies Inc (BioTek Instruments Inc)

      6. 6.1.6 GE Healthcare

      7. 6.1.7 Perkin Elmer Inc

      8. 6.1.8 Biological Industry

      9. 6.1.9 Biotium

      10. 6.1.10 Mindray Medical International Limited

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The undefined market is studied from 2018 - 2026.

The undefined is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Merck KGaA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Becton, Dickinson and Company, Agilent Technologies Inc (BioTek Instruments Inc) are the major companies operating in undefined.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!